Michael Main, MD
NPI 1649833005ActiveIndividual· Internal Medicine, Allergy & Immunology· San Francisco, CA
Internal Medicine, Allergy & Immunology (MD) in San Francisco, California, trained at New York University School of Medicine (class of 2019). Mostly services rather than prescriptions: Medicare paid $16,419 for 40 patients in 2024, with only 49 Part D claims. Astrazeneca Pharmaceuticals LP was the largest of 9 companies reporting payments in 2025, $673.57 in all, mostly food and beverage.
Overview
| NPI | 1649833005 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Apr 20, 2019 |
| Last updated in NPPES | Oct 13, 2024 |
| Certified by provider | Oct 13, 2024 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Allergy & Immunology Primary | 207RA0201X | A178576 | CA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Allergy/Immunology (CA) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 40 |
|---|---|
| Services billed | 732 across 17 procedure codes |
| Paid by Medicare | $16,419 |
Part D prescriptions in 2024
| Prescriptions (claims) | 49 · 59 30-day fills |
|---|---|
| Patients | 28 |
| Total drug cost | $7,122 |
| Generic share | 67% of claims |
Education and affiliations
| Medical school | New York University School of Medicine |
|---|---|
| Graduation year | 2019 |
| Medicare specialty | Allergy/Immunology |
| Telehealth | Offers telehealth |
Medical group
- Regents of the University of California - UCSFSan Francisco, CA · 80 clinicians
Industry payments (Open Payments)
- 2025$673.57 · 27 payments from 9 companies
- 2024$205.28 · 7 payments from 5 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $235.47 | 8 |
| Glaxosmithkline, LLC. | $142.97 | 8 |
| Regeneron Healthcare Solutions, Inc. | $68.34 | 2 |
| Amgen Inc. | $54.49 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $43.67 | 2 |
What the 2025 payments were for
- Food and Beverage$673.57 · 27 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Allergy & Immunology providers in San Francisco
- 1164522165
- 1194169300
- 1235556432
- 1285925990
- 1518461268
- 1780047779
- 1174815815
- 1215390166
- 1528695707
- 1205964285
- 1528403797
- 1588867535
All Internal Medicine, Allergy & Immunology providers in California